These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25000820)

  • 1. Solid-phase biological assays for drug discovery.
    Forsberg EM; Sicard C; Brennan JD
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():337-59. PubMed ID: 25000820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase assays for small molecule screening using sol-gel entrapped proteins.
    Lebert JM; Forsberg EM; Brennan JD
    Biochem Cell Biol; 2008 Apr; 86(2):100-10. PubMed ID: 18443623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
    Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
    Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
    Zhu Z; Cuozzo J
    J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guided materials screening approach for developing quantitative sol-gel derived protein microarrays.
    Helka BJ; Brennan JD
    J Vis Exp; 2013 Aug; (78):. PubMed ID: 24022739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment screening using X-ray crystallography.
    Davies TG; Tickle IJ
    Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional protein micropatterning for drug design and discovery.
    You C; Piehler J
    Expert Opin Drug Discov; 2016; 11(1):105-19. PubMed ID: 26624534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of PI3K assays for novel drug discovery.
    Yanamandra M; Mitra S; Giri A
    Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs.
    Feng Y; Wang B; Chu X; Wang Y; Zhu L
    Mini Rev Med Chem; 2016; 16(10):846-50. PubMed ID: 25963567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorous-based small-molecule microarrays for protein, antibody and enzyme screening.
    Song EH; Pohl NL
    Future Med Chem; 2009 Aug; 1(5):889-96. PubMed ID: 21426087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and utilization of activated STAT3 detection assays for screening a library of secreted proteins.
    Fursov N; Gates IV; Panavas T; Giles-Komar J; Powers G
    Assay Drug Dev Technol; 2011 Aug; 9(4):420-9. PubMed ID: 21294636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Based Ligand Discovery for the ENL YEATS Domain.
    Asiaban JN; Milosevich N; Chen E; Bishop TR; Wang J; Zhang Y; Ackerman CJ; Hampton EN; Young TS; Hull MV; Cravatt BF; Erb MA
    ACS Chem Biol; 2020 Apr; 15(4):895-903. PubMed ID: 32176478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in Assay Technologies and Strategies to Enable Drug Discovery.
    Busby SA; Carbonneau S; Concannon J; Dumelin CE; Lee Y; Numao S; Renaud N; Smith TM; Auld DS
    ACS Chem Biol; 2020 Oct; 15(10):2636-2648. PubMed ID: 32880443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Small-Molecule Aggregation with High-Throughput Microplate Biophysical Methods.
    Allen SJ; Dower CM; Liu AX; Lumb KJ
    Curr Protoc Chem Biol; 2020 Mar; 12(1):e78. PubMed ID: 32150343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revolution of Small Molecule Drug Discovery by Affinity Selection-Mass Spectrometry Technology.
    Motoyaji T
    Chem Pharm Bull (Tokyo); 2020; 68(3):191-193. PubMed ID: 32115525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.